ICUI icumed.com: Company Value to Revenue

Official company branding of ICU Medical (ICUI)

The EV/Sales multiple displayed on this chart by GURU.Markets demonstrates the market consensus, where 2426.81 determines the current status of the parameter. ICU Medical, Inc. (ICUI) generates revenue from the sale of infusion systems and catheters. Long-term procurement of consumables by clinics ensures margin stability. Business resilience is further bolstered by the loyalty of R&D specialists and quality experts.

icumed.com (ICUI): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

ICUI (ICU Medical Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental company valuation:ICUI (ICU Medical, Inc.)
Manufactured products of ICU Medical Corp

For infusion systems manufacturer ICU Medical, Inc. (ICUI), whose model relies on strict FDA standards and a highly qualified engineering staff, this metric determines the market value of the business excluding debt load. By analyzing the enterprise value-to-annual revenue multiple on the GURU.Markets platform, an investor assesses the company's real capital, eliminating distortions from leverage, which allows for the timely identification of asset overvaluation or undervaluation.

Competitor analysis for ICU Medical, Inc.

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|XRAY: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple